The Biosimilars industry is experiencing significant growth due to the rising incidence of chronic diseases and the increasing demand for biosimilars due to their cost-effectiveness. The global biosimilars market size is expected to grow from USD 35.7 billion by 2025 from USD 11.8 billion in 2020, at a CAGR of 24.7%. However, with complexities in manufacturing and resistance from biologic manufacturers, such factors keeps adding to the hinderance in their development.
3rd Annual MarketsandMarkets Biosimilars Conference will a hold discussions on key clinical attributes of biosimilars, perspective from different stakeholder regarding opportunities for the biosimilar market and how intense can the competition get.
The conference will also address perspective on global regulatory landscape and how partnerships can highly support R&D and production of biosimilars. Witness discussions on importance of market access and marketing strategy and how should companies enhance their presence in the market.
CEO, CSO, CMO, Director, VP, Head, Manager, and Research fellows from pharmaceutical and biotech company working in: